Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» CAR-T
CAR-T
Beam jumps back into off-the-shelf CAR-T race after FDA lifts clinical hold
Fierce Biotech
Fri, 12/2/22 - 11:03 am
Beam Therapeutics
FDA
CAR-T
clinical trials
BEAM-201
Sana lays off 15%, trims pipeline to keep funding flowing to off-the-shelf CAR-Ts
Fierce Biotech
Wed, 11/30/22 - 10:43 am
Sana Biotechnology
layoffs
CAR-T
cell therapy
Pulling back the curtain on AstraZeneca’s CAR-T work
EP Vantage
Fri, 11/18/22 - 10:23 am
AstraZeneca
CAR-T
AZD0754
cell theray
Gilead dodges Supreme Court review—and a $1.2B fine—in CAR-T patent feud with Bristol Myers
Fierce Pharma
Mon, 11/7/22 - 05:48 pm
Gilead Sciences
Kite Pharma
Bristol Myers Squibb
cell therapy
legal
CAR-T
Yescarta
Ash 2022 preview – Affimed and Aptose score
EP Vantage
Sun, 11/6/22 - 01:24 pm
ASH 2022
Affimed
Aptose Biosciences
ADI-001
CAR-T
AFM13
Galapagos lays off 200 staff, drops kidney and fibrosis programs in renewed CAR-T push
Fierce Biotech
Fri, 11/4/22 - 11:01 am
Galapagos
layoffs
CAR-T
Candel Pairs HSV Vectors with Carl June's CAR-T Cells in Solid Tumor Pact
BioSpace
Thu, 10/27/22 - 10:54 am
Candel Therapeutics
HSV vectors
CAR-T
solid tumors
Gilead, working to improve cancer cell therapy, partners with California startup
BioPharma Dive
Thu, 10/20/22 - 11:28 pm
Gilead Sciences
Refuge Biotechnologies
CAR-T
Kyverna Files First IND to Leverage CAR-T Therapy for Lupus
BioSpace
Thu, 10/20/22 - 10:32 am
Kyverna Therapeutics
KYV-101
CAR-T
lupus nephritis
Inceptor, Avectas are latest biotechs to take up solid tumor CAR-T challenge
Fierce Biotech
Wed, 10/12/22 - 11:44 pm
Inceptor Bio
Avectas
solid tumors
CAR-T
cell therapy
Allogene Therapeutics debuts CAR T Together to expand treatment access
Medical Marketing and Media
Wed, 10/12/22 - 10:57 am
Allogene Therapeutics
pharma marketing
cancer
CAR-T
Allogene Therapeutics Initiates Industry’s First Allogeneic CAR T Phase 2 Trial
Global Newswire
Thu, 10/6/22 - 07:06 pm
Allogene
large B cell lymphoma
clinical trials
ALLO-501a
CAR-T
Beam reveals what tripped up its base-edited, off-the-shelf CAR-T as it tries to clear FDA hold
Endpoints
Tue, 08/30/22 - 11:50 am
Beam Therapeutics
FDA
CAR-T
Gilead hits back at Bristol Myers' Supreme Court petition in CAR-T patent feud
Fierce Pharma
Sun, 08/28/22 - 10:19 pm
Gilead Sciences
CAR-T
patents
Supreme Court
Kite Pharma
Bristol Myers Squibb
Regen BioPharma Develops Novel Means of Using CAR-T cell Immunotherapy to Attack Solid Tumors
Guru Focus
Thu, 08/25/22 - 07:58 pm
Regen Biopharma
solid tumors
CAR-T
cell therapy cancer
Flush with $126M raise, Tessa Therapeutics woos new CEO from Takeda
Endpoints
Mon, 08/22/22 - 10:04 am
Tessa Therapeutics
Takeda
Thomas Willemsen
CAR-T
Pharma CEOs
Anixa starts subject treatment in Phase I ovarian cancer cell therapy trial
Clinical Trials Arena
Tue, 08/16/22 - 11:12 am
Anixa Biosciences
clinical trials
CAR-T
ovarian cancer
Bristol Myers claims success in study testing earlier CAR-T use in multiple myeloma
BioPharma Dive
Wed, 08/10/22 - 11:34 pm
Bristol Myers Squibb
2seventy bio
Abecma
CAR-T
Multiple Myeloma
Galapagos cleans closet of another 4 programs to make room for CAR-T ambitions
Fierce Biotech
Sun, 08/7/22 - 11:22 pm
Galapagos
CAR-T
ElevateBio, Boston Children’s launch startup to test new approach to ‘off-the-shelf’ cell therapy
BioPharma Dive
Fri, 08/5/22 - 10:36 am
ElevateBio
cell therapy
pediatric
Boston Children's Hospital
CAR-T
cancer
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »